Aptevo Therapeutics Inc. Stock-Based Compensation
Aptevo Therapeutics Inc. (APVO) reported Stock-Based Compensation of $115.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- Aptevo Therapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $58.00K.
- Aptevo Therapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $57.00K, a 68.33% decline year-over-year.
- Aptevo Therapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.00K.
- Aptevo Therapeutics Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $77.00K, a 48.32% decline year-over-year.
- Aptevo Therapeutics Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $96.00K, a 91.02% decline from fiscal 2024.
- Aptevo Therapeutics Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $1.07M, a 51.25% decline from fiscal 2023.
- Aptevo Therapeutics Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $2.19M, a 21.70% increase from fiscal 2022.
- Aptevo Therapeutics Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $1.80M, a 9.68% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $115.00K 10-Q · filed 2026-08-14 | $117.00K derived: sum of 3 quarters · filed 2026-08-14 | $194.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $57.00K 10-Q · filed 2026-05-13 | $59.00K derived: sum of 2 quarters · filed 2026-05-13 | $136.00K derived: sum of 3 quarters · filed 2026-05-13 | -$27.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $79.00K derived: sum of 2 quarters · filed 2026-03-26 | -$84.00K derived: sum of 3 quarters · filed 2026-08-14 | $96.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$86.00K derived: sum of 2 quarters · filed 2026-08-14 | $94.00K 10-Q · filed 2025-11-06 | $22.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $17.00K 10-Q · filed 2026-08-14 | -$55.00K derived: sum of 3 quarters · filed 2026-08-14 | $94.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $180.00K 10-Q · filed 2026-05-13 | $108.00K derived: sum of 2 quarters · filed 2026-05-13 | $257.00K derived: sum of 3 quarters · filed 2026-05-13 | $530.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $77.00K derived: sum of 2 quarters · filed 2026-03-26 | $350.00K derived: sum of 3 quarters · filed 2026-03-26 | $1.07M 10-K · filed 2026-03-26 |
| 2024-09-30 | $149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $422.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.14M 10-Q · filed 2025-11-06 | $1.50M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $273.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $992.00K 10-Q · filed 2025-08-11 | $1.35M derived: sum of 3 quarters · filed 2025-08-11 | $1.80M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $719.00K 10-Q · filed 2025-05-15 | $1.08M derived: sum of 2 quarters · filed 2025-05-15 | $1.53M derived: sum of 3 quarters · filed 2025-05-15 | $2.00M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $358.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $813.00K derived: sum of 2 quarters · filed 2025-02-14 | $1.28M derived: sum of 3 quarters · filed 2025-02-14 | $2.19M 10-K · filed 2025-02-14 |
| 2023-09-30 | $455.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $920.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.83M 10-Q · filed 2024-11-07 | $2.19M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $465.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.38M 10-Q · filed 2024-08-08 | $1.74M derived: sum of 3 quarters · filed 2024-08-08 | $2.10M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $915.00K 10-Q · filed 2024-05-08 | $1.27M derived: sum of 2 quarters · filed 2024-05-08 | $1.63M derived: sum of 3 quarters · filed 2024-05-08 | $2.12M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $716.00K derived: sum of 2 quarters · filed 2024-03-05 | $1.20M derived: sum of 3 quarters · filed 2024-03-05 | $1.80M 10-K · filed 2024-03-05 |
| 2022-09-30 | $359.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $844.00K derived: sum of 2 quarters · filed 2023-11-14 | $1.45M 10-Q · filed 2023-11-14 | $1.62M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $485.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.09M 10-Q · filed 2023-08-10 | $1.26M derived: sum of 3 quarters · filed 2023-08-10 | $1.58M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $601.00K 10-Q · filed 2023-05-11 | $779.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.10M derived: sum of 3 quarters · filed 2023-05-11 | $1.67M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $497.00K derived: sum of 2 quarters · filed 2023-03-30 | $1.07M derived: sum of 3 quarters · filed 2023-03-30 | $1.64M 10-K · filed 2023-03-30 |
| 2021-09-30 | $319.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $891.00K derived: sum of 2 quarters · filed 2022-11-10 | $1.47M 10-Q · filed 2022-11-10 | $1.66M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $572.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.15M 10-Q · filed 2022-08-11 | $1.34M derived: sum of 3 quarters · filed 2022-08-11 | $1.69M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $574.00K 10-Q · filed 2022-05-12 | $772.00K derived: sum of 2 quarters · filed 2022-05-12 | $1.11M derived: sum of 3 quarters · filed 2022-05-12 | $1.42M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $198.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $541.00K derived: sum of 2 quarters · filed 2022-03-24 | $842.00K derived: sum of 3 quarters · filed 2022-03-24 | $1.25M 10-K · filed 2022-03-24 |
| 2020-09-30 | $343.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $644.00K derived: sum of 2 quarters · filed 2021-11-12 | $1.06M 10-Q · filed 2021-11-12 | $1.33M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $714.00K 10-Q · filed 2021-08-12 | $983.00K derived: sum of 3 quarters · filed 2021-08-12 | $1.32M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $413.00K 10-Q · filed 2021-05-11 | $682.00K derived: sum of 2 quarters · filed 2021-05-11 | $1.02M derived: sum of 3 quarters · filed 2021-05-11 | $1.42M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $269.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $603.00K derived: sum of 2 quarters · filed 2021-03-31 | $1.00M derived: sum of 3 quarters · filed 2021-03-31 | $1.60M 10-K · filed 2021-03-31 |
| 2019-09-30 | $334.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $735.00K derived: sum of 2 quarters · filed 2020-11-10 | $1.33M 10-Q · filed 2020-11-10 | $1.82M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $401.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $995.00K 10-Q · filed 2020-08-14 | $1.49M derived: sum of 3 quarters · filed 2020-08-14 | $1.97M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $594.00K 10-Q · filed 2020-05-13 | $1.09M derived: sum of 2 quarters · filed 2020-05-13 | $1.57M derived: sum of 3 quarters · filed 2020-05-13 | $2.02M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $493.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $974.00K derived: sum of 2 quarters · filed 2020-03-25 | $1.42M derived: sum of 3 quarters · filed 2020-03-25 | $2.14M 10-K · filed 2020-03-25 |
| 2018-09-30 | $481.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $930.00K derived: sum of 2 quarters · filed 2019-11-07 | $1.65M 10-Q · filed 2019-11-07 | $2.70M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $449.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.17M 10-Q · filed 2019-08-09 | $2.22M derived: sum of 3 quarters · filed 2019-08-09 | $3.27M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $717.00K 10-Q · filed 2019-05-09 | $1.77M derived: sum of 2 quarters · filed 2019-05-09 | $2.82M derived: sum of 3 quarters · filed 2019-05-09 | $3.92M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $2.10M derived: sum of 2 quarters · filed 2019-03-18 | $3.21M derived: sum of 3 quarters · filed 2019-03-18 | $4.88M 10-K · filed 2019-03-18 |
| 2017-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $2.15M derived: sum of 2 quarters · filed 2018-11-14 | $3.83M 10-Q · filed 2018-11-14 | $5.57M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $2.78M 10-Q · filed 2018-08-09 | $4.52M derived: sum of 3 quarters · filed 2018-08-09 | $5.85M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $1.68M 10-Q · filed 2018-05-10 | $3.42M derived: sum of 2 quarters · filed 2018-05-10 | $4.75M derived: sum of 3 quarters · filed 2018-05-10 | $5.15M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $3.08M derived: sum of 2 quarters · filed 2018-03-13 | $3.48M derived: sum of 3 quarters · filed 2018-03-13 | $3.81M 10-K · filed 2018-03-13 |
| 2016-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $1.73M derived: sum of 2 quarters · filed 2017-11-13 | $2.07M 10-Q · filed 2017-11-13 | $2.35M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $734.00K 10-Q · filed 2017-08-10 | $1.02M derived: sum of 3 quarters · filed 2017-08-10 | $1.30M derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | $334.00K 10-Q · filed 2017-05-12 | $619.00K derived: sum of 2 quarters · filed 2017-05-12 | $900.00K derived: sum of 3 quarters · filed 2017-05-12 | |
| 2015-12-31 | $285.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $566.00K derived: sum of 2 quarters · filed 2017-03-31 | $1.11M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $281.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-14 | $822.00K 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $541.00K 10-Q/A · filed 2016-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |